Healthcare provider profile · identity verified

David Bartholomew Sze, MD

Internal Medicine · GREEN BAY, WI · NPI 1770502312

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	850	290
Omeprazole	Omeprazole	356	118
Lisinopril	Lisinopril	328	120
Pantoprazole Sodium	Pantoprazole Sodium	251	82
Gabapentin	Gabapentin	250	86
Tizanidine Hcl	Tizanidine Hcl	244	87
Losartan Potassium	Losartan Potassium	212	84
Levothyroxine Sodium	Levothyroxine Sodium	206	65
Metformin Hcl Er	Metformin Hcl	189	74
Amitriptyline Hcl	Amitriptyline Hcl	166	49
Amlodipine Besylate	Amlodipine Besylate	164	54
Duloxetine Hcl	Duloxetine Hcl	164	43
Tamsulosin Hcl	Tamsulosin Hcl	160	61
Metoprolol Succinate	Metoprolol Succinate	153	49
Albuterol Sulfate Hfa	Albuterol Sulfate	138	60
Simvastatin	Simvastatin	132	46
Furosemide	Furosemide	128	50
Jardiance	Empagliflozin	124	35
Acarbose	Acarbose	123	44
Rosuvastatin Calcium	Rosuvastatin Calcium	122	40
Buspirone Hcl	Buspirone Hcl	108	40
Mirtazapine	Mirtazapine	102	40
Fluticasone Propionate	Fluticasone Propionate	101	43
Glipizide	Glipizide	99	41
Metformin Hcl	Metformin Hcl	97	31
Allopurinol	Allopurinol	96	34
Metoprolol Tartrate	Metoprolol Tartrate	95	32
Atenolol	Atenolol	93	34
Trazodone Hcl	Trazodone Hcl	85	26
Finasteride	Finasteride	81	27
Montelukast Sodium	Montelukast Sodium	79	25
Eliquis	Apixaban	78	26
Zolpidem Tartrate	Zolpidem Tartrate	78	28
Fluoxetine Hcl	Fluoxetine Hcl	77	24
Ezetimibe	Ezetimibe	74	25
Potassium Chloride	Potassium Chloride	71	24
Clopidogrel	Clopidogrel Bisulfate	70	25
Tramadol Hcl	Tramadol Hcl	67	24
Famotidine	Famotidine	65	20
Clonazepam	Clonazepam	63	19
Hydrochlorothiazide	Hydrochlorothiazide	63	27
Warfarin Sodium	Warfarin Sodium	63	22
Alendronate Sodium	Alendronate Sodium	62	23
Bupropion Hcl Sr	Bupropion Hcl	61	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	19
Sertraline Hcl	Sertraline Hcl	61	24
Meloxicam	Meloxicam	59	30
Ibandronate Sodium	Ibandronate Sodium	58	17
Carvedilol	Carvedilol	57	22
Prednisone	Prednisone	56	38
Lorazepam	Lorazepam	55	22
Pregabalin	Pregabalin	55	17
Alprazolam	Alprazolam	50	22
Fenofibrate	Fenofibrate	49	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	17
Donepezil Hcl	Donepezil Hcl	48	suppressed
Ipratropium Bromide	Ipratropium Bromide	46	29
Clonidine Hcl	Clonidine Hcl	45	13
Pravastatin Sodium	Pravastatin Sodium	45	14
Acetaminophen-Codeine	Acetaminophen With Codeine	44	13
Oxybutynin Chloride Er	Oxybutynin Chloride	43	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	16
Trulicity	Dulaglutide	42	15
Mounjaro	Tirzepatide	41	13
Escitalopram Oxalate	Escitalopram Oxalate	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	15
Memantine Hcl	Memantine Hcl	37	11
Ropinirole Hcl	Ropinirole Hcl	37	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	18
Lovastatin	Lovastatin	35	14
Nystatin	Nystatin	34	17
Wixela Inhub	Fluticasone Propion/Salmeterol	33	11
Topiramate	Topiramate	32	11
Enalapril Maleate	Enalapril Maleate	31	suppressed
Spironolactone	Spironolactone	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	31	14
Lactulose	Lactulose	30	15
Glipizide Er	Glipizide	29	11
Hydroxyzine Hcl	Hydroxyzine Hcl	29	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	19
Fenofibrate	Fenofibrate,micronized	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Baclofen	Baclofen	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Primidone	Primidone	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Naltrexone Hcl	Naltrexone Hcl	23	suppressed
Celecoxib	Celecoxib	22	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Ozempic	Semaglutide	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valsartan	Valsartan	22	suppressed
Bydureon Bcise	Exenatide Microspheres	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Zonisamide	Zonisamide	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Estradiol	Estradiol	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nadolol	Nadolol	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error